Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Weight-loss drug Wegovy to hit market on Tuesday
Weight-loss drug Wegovy will go on sale in Korea on Tuesday, with the much-anticipated injectable drug available for order through Zeullig Pharma Korea.
France won’t pay for weight loss drug Wegovy. What about other European countries?
France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on euronews
Most Americans who want to lose weight don’t want to take GLP-1 drugs like Wegovy and Zepbound, new survey says
Men, Baby Boomers, and postgraduate degree-holders were among those most likely to say they wouldn’t choose medication over dieting.
Offering Wegovy and other weight loss drugs on Medicare could cost $35 billion
Allowing Medicare to cover popular weight loss drugs such as Wegovy and Zepbound could increase federal spending by billions of dollars, according to a new report by the Congressional Budget Office (CBO).
Wegovy weight loss: The science and the hype
Originally approved to help with excess weight and obesity, the injectable Wegovy and its sibling-product Ozempic, which is for type 2 diabetes, have become synonymous with weight loss fads. Here's what you need to know.
WeightWatchers stock price skyrockets on news that it will offer a compounded GLP-1 weight-loss drug like Wegovy
The embattled diet brand said it is adding a compounded weight-loss drug in accordance with FDA rules and manufacturing standards. WeightWatchers announced on Tuesday that it will offer a compounded version of Novo Nordisk‘s popular weight-loss drug Wegovy as part of its weight-management programs,
What Is Wegovy? Doctors Explain the Injectable Weight-Loss Drug
While medications like Ozempic originally dominated the weight-loss space, Wegovy is another injectable prescription weight-loss drug worth knowing about. When properly prescribed, it's been shown to help people lose weight and keep it off,
3d
on MSN
Wegovy and Zepbound rival targeting ‘next generation' of obesity drugs, Zealand Pharma CEO says
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market ...
3d
Wegovy maker Novo Nordisk bets big on talent, AI partnerships in India
Novo Nordisk , whose global profile has risen along with demand for its Wegovy weight-loss drug, is bolstering operations in ...
13d
U.S. Rep. Lloyd Doggett pushes for generic Wegovy, Ozempic to lessen costs
U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...
3d
Best OTC Wegovy Alternatives: Natural Options for Effective Weight Management
Zmyra is known as the top over-the-counter alternative to Wegovy for weight loss. This natural supplement packs a punch with ...
tyla
3d
Difference between Ozempic, Wegovy, Mounjaro and Saxenda explained
Unlike Ozempic, Wegovy is approved for weight management even though they both contain semaglutide. However, they do have ...
12d
on MSN
2 NC Republicans clash over why the State Health Plan cut coverage of Wegovy, Saxenda
State workers’ access to weight loss drugs has put House Speaker Tim Moore at odds with State Treasurer Dale Folwell, who ran ...
Neuroscience News
7d
Study Finds Wegovy Reduces COVID-19 Death Risk by One-Third
A new trial reveals that weekly injections of the weight-loss drug Wegovy (semaglutide) lowered the risk of death from COVID-19 by about a third and reduced overall mortality by 19%.
15h
Thousands of people with life-threatening obesity denied access to weight-loss jab Wegovy
Doctors have said access to the drug is a "postcode lottery" as Sky News analysis reveals just 800 people have been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Weight Watchers
Novo Nordisk
Ozempic
France
Semaglutide
Feedback